IVRN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
IVRN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-09-20), Innoveren Scientific's share price is $0.005. Innoveren Scientific's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.42. Hence, Innoveren Scientific's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Innoveren Scientific's Price-to-Operating-Cash-Flow or its related term are showing as below:
Innoveren Scientific's Cash Flow from Operations per share for the three months ended in Sep. 2023 was $-0.48. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.42.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 63.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 48.30% per year.
During the past 10 years, Innoveren Scientific's highest 3-Year average Operating Cash Flow per Share Growth Rate was 63.00% per year. The lowest was -87.10% per year. And the median was 32.60% per year.
The historical data trend for Innoveren Scientific's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innoveren Scientific Annual Data | |||||||||||||||||||||
Trend | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | |||||||||||
Price-to-Operating-Cash-Flow | Get a 7-Day Free Trial | - | - | - | - | - |
Innoveren Scientific Quarterly Data | ||||||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Price-to-Operating-Cash-Flow | Get a 7-Day Free Trial | - | - | - | - | - |
For the Biotechnology subindustry, Innoveren Scientific's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Innoveren Scientific's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Innoveren Scientific's Price-to-Operating-Cash-Flow falls into.
Innoveren Scientific's Price-to-Operating-Cash-Flow ratio for today is calculated as
Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
= | 0.005 | / | -1.422 | |
= |
Innoveren Scientific's Share Price of today is $0.005.
Innoveren Scientific's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.42.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Price-to-Operating-Cash-Flow Ratio | = | Market Cap | / | Cash Flow from Operations |
Thank you for viewing the detailed overview of Innoveren Scientific's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Fwhc Holdings, Llc | 10 percent owner | 1306 W KENNEDY BOULEVARD, TAMPA FL 33606 |
Hoa Capital Llc | 10 percent owner | 1306 W KENNEDY BOULEVARD, TAMPA FL 33606 |
Farrior J Rex Iii | 10 percent owner | 1306 W KENNEDY BOULEVARD, TAMPA FL 33606 |
Fwhc Bridge Friends, Llc | 10 percent owner | 1306 W KENNEDY BOULEVARD, TAMPA FL 33606 |
Raymond Monteleone | director | 201 E KENNEDY BLVD, STE 700, TAMPA FL 33602 |
Jeremy Daniel | officer: Chief Financial Officer | 201 E KENNEDY AVE, STE 700, TAMPA FL 33602 |
Robert Smith Greif | officer: President and C.E.O. | 19 MAY STREET, NEEDHAM MA 02492 |
Cfrs Investments, Llc | 10 percent owner | 2903 W VILLA ROSA PARK, TAMPA FL 33611 |
Frederick J Lynch | 10 percent owner | C/O MASONITE INTERNATIONAL CORPORATION, 201 NORTH FRANKLIN ST., SUITE 300, TAMPA FL 33602 |
Fwhc Bridge, Llc | 10 percent owner | 334 EAST LAKE ROAD, SUITE 176, PALM HARBOT FL 34685 |
Todd R Wagner | 10 percent owner | 3385 OLD KEYSTONE ROAD, TARPON SPRINGS FL 34688 |
Michael Yurkowsky | director | 2380 OLD MILTON PARKWAY, ALPHARETTA GA 30009 |
William E Horne | director, officer: Chief Executive Officer | 201 EAST KENNEDY BLVD, SUITE 700, TAMPA FL 33602 |
Jon Mogford | director | 714 PLUM HOLLOW DRIVE, COLLEGE STATION TX 77845 |
John C Thomas | director | 8601 SIX FORKS ROAD, SUITE 160, RALEIGH NC 27615 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 03-04-2022
By Marketwired Marketwired • 01-15-2019
By Marketwired Marketwired • 09-30-2020
By Marketwired Marketwired • 07-06-2021
By ACCESSWIRE • 10-04-2023
By Marketwired Marketwired • 03-18-2019
By Marketwired Marketwired • 04-29-2019
By Marketwired Marketwired • 09-08-2021
By Marketwired Marketwired • 06-29-2021
By Marketwired Marketwired • 01-21-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.